Inspire Announces Peer-Reviewed Publications Related to Denufosol for Cystic Fibrosis

Inspire Provides Update on Cystic Fibrosis Clinical Program
-Optimization of TIGER-2 Trial Design -

Inspire Announces Date for Conference Call to Discuss Second Quarter 2008 Financial Results
Monday, August 11, 2008 with Conference Call at 10:00 am ET
Webcast Link
    Conference Call:
    877-648-7970 (US)
    706-902-0415 (International)
    ID # 56982011

    Replay Conference Call
    800-642-1687 (US)
    706-645-9291(International)
    ID number is 56982011
    (available until August 25, 2008)

Inspire Announces Webcast of Presentation at Collins Stewart Growth Conference
Webcast Link

Inspire Named One of The "BEST PLACES TO WORK" in 2008 by The Scientist Magazine
-Company Also Receives Two Employee Wellness Awards-

Inspire Announces Webcast of Presentation at Piper Jaffray Europe Conference

Inspire Announces Achievement of Primary Endpoint in Phase 3 Trial with Denufosol for Cystic Fibrosis

Inspire Receives Milestone Payment for Completion of Phase 3 Testing in Japan for Dry Eye Program

Inspire Reports First Quarter 2008 Financial Results - Q1 2008 Revenue Increased by 35% over Q1 2007

Inspire Announces Poster Presentations at 2008 Association for Research in Vision and Ophthalmology Annual Meeting

Inspire Announces Webcasts of Presentations at Morgan Stanley and Deutsche Bank Healthcare Conferences

Inspire to Discontinue Development of Epinastine Nasal Spray

Inspire Announces Poster Presentation at American Society of Cataract and Refractive Surgery Annual Symposium

Page last updated: 06-Aug-2008